A-share flu-related stocks were repeatedly active, with Jindike rising more than 13%, Zhong Sheng Pharmaceutical previously hitting the daily limit, achieving two limit-up days in three days, and Hualan Vaccine, Jinshi Pharmaceutical, and Teyi Pharmaceutical following suit.